M Holdings Securities Inc. bought a new stake in shares of The Clorox Company (NYSE:CLX – Free Report) during the 3rd quarter, Holdings Channel reports. The firm bought 21,394 shares of the company’s stock, valued at approximately $1,919,000.
A number of other institutional investors have also recently made changes to their positions in CLX. Geneos Wealth Management Inc. grew its stake in shares of Clorox by 9.3% in the first quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company’s stock worth $145,000 after acquiring an additional 119 shares during the period. Elevation Wealth Partners LLC lifted its position in Clorox by 32.3% during the third quarter. Elevation Wealth Partners LLC now owns 565 shares of the company’s stock valued at $46,000 after purchasing an additional 138 shares during the period. Eastern Bank lifted its position in Clorox by 3.1% during the third quarter. Eastern Bank now owns 5,052 shares of the company’s stock valued at $409,000 after purchasing an additional 150 shares during the period. Mystic Asset Management Inc. lifted its position in Clorox by 1.3% during the third quarter. Mystic Asset Management Inc. now owns 12,112 shares of the company’s stock valued at $981,000 after purchasing an additional 153 shares during the period. Finally, Meeder Advisory Services Inc. boosted its holdings in Clorox by 5.0% in the first quarter. Meeder Advisory Services Inc. now owns 3,228 shares of the company’s stock worth $335,000 after purchasing an additional 154 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Clorox Price Performance
Shares of NYSE:CLX opened at $105.29 on Tuesday. The company has a quick ratio of 0.38, a current ratio of 0.65 and a debt-to-equity ratio of 32.91. The stock has a market capitalization of $12.76 billion, a PE ratio of 18.94, a price-to-earnings-growth ratio of 3.22 and a beta of 0.59. The firm’s 50 day moving average price is $87.77 and its 200-day moving average price is $99.64. The Clorox Company has a twelve month low of $79.12 and a twelve month high of $128.90.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Monday, November 2nd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.48. Clorox had a net margin of 9.41% and a return on equity of 608.30%. The company had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.88 billion. During the same period in the previous year, the business posted $0.85 earnings per share. The firm’s quarterly revenue was up 33.3% compared to the same quarter last year. Equities research analysts expect that The Clorox Company will post 5.75 EPS for the current year.
Clorox Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be given a $1.25 dividend. The ex-dividend date is Wednesday, October 28th. This represents a $5.00 dividend on an annualized basis and a yield of 4.7%. Clorox’s dividend payout ratio is presently 89.93%.
Insider Buying and Selling
In related news, Director Pierre Breber acquired 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The stock was bought at an average cost of $100.06 per share, for a total transaction of $400,240.00. Following the purchase, the director owned 22,000 shares in the company, valued at $2,201,320. The trade was a 22.22% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.51% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on CLX shares. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $74.00 target price on shares of Clorox in a research report on Tuesday, November 3rd. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $95.00 price target on shares of Clorox in a report on Monday, October 19th. UBS Group set a $88.00 price target on Clorox in a research note on Tuesday, November 3rd. Morgan Stanley lifted their price objective on Clorox from $87.00 to $94.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 4th. Finally, BNP Paribas Exane cut their price objective on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a report on Monday, July 20th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Reduce” and an average price target of $93.79.
Check Out Our Latest Stock Report on CLX
Clorox Company Profile
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care.
Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
Clorox serves consumers primarily in the United States and also sells products in international markets.
Featured Stories
- Five stocks we like better than Clorox
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
